Both in Pharmaceuticals
Phibro Animal Health vs Ocular Therapeutix
Over the past year PAHC returned −10.7% and OCUL returned −41.0%; their daily moves had a correlation of 0.09.
PAHC −10.7% OCUL −41.0%Growth of $1, one year, split-adjusted
| Metric | PAHC | OCUL |
|---|---|---|
| Price | $38.74 | $6.73 |
| Market cap | $1.57B | $1.48B |
| Today | −0.36% | −3.44% |
| 1 month | +4.0% | −3.3% |
| 6 months | −29.2% | −31.1% |
| Year to date | +3.7% | −44.6% |
| 1 year | −7.5% | −43.1% |
| Revenue growth (YoY) | +4.8% | +0.1% |
| Gross margin | 33.9% | 85.1% |
| Net margin | 5.5% | −584.5% |
| P/E (TTM) | 15.8× | — |
| Price / sales | 1.0× | 28.4× |
| Net cash | -$650.8M | $525.8M |
| Dividend yield | 1.24% | — |
| Volatility (60d) | 29.5% | 75.6% |
| Short % of float | 4.9% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).